The Impact of COVID-19 and the Winter Season on Substance Use Disorders

In this week’s episode, Marie Cleary-Fishman, vice president of clinical quality at the AHA Center for Health Innovation is joined by Debra Houry, MD, MPH, director of the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention, to discuss how to navigate the opioid epidemic amid the emotional triggers brought on by COVID-19 and the post-holiday, winter blues. Seasonal affects, such as hibernation and loneliness, can lead to a gloomy outlook and make people feel hopeless. Hospitals and health systems can proactively identify patient needs and offer solutions to avoid increasing uses of opioids and other substances in their communities.


 

Related Resources

Letter/Comment
Public
The AHA along with eight other health organizations urge Congress to provide additional funding for health care providers in the current reconciliation package.
Videos
During an AHA virtual briefing for lawmakers and staff, leaders from three health systems — One Brooklyn Health System, Grady Health System, and The Hospitals…
Videos
Member Non-Fed
During a Feb. 23 AHA Advocacy Day briefing, AHA provided hospital and health system leaders with the latest intelligence from Capitol Hill and the information…
Advancing Health Podcast
Public
In this AHA Physician Alliance podcast, Janine Adjo, M.D., chair and director of the pediatric residency program at SBH Health System Bronx, shares how she…
Special Bulletin
Member
The Coalition to Protect America’s Health Care, of which the AHA is a founding member, today launched a new TV ad urging Congress to provide critical resources…
Action Alert
Member Non-Fed
Congress is back in Washington, D.C., and its top focus will be passing President Biden’s $1.9 trillion COVID-19 relief legislation.